Skip to contentC
Cytosorbents Corp
C
CTSOCytosorbents Corp Q2 2013 · 10-Q
Revenue$291.48K$291.48Kno prior Q2 2012 on file Net Income-$1.41M-$1.41MN/M vs Q2 2012 EPS Diluted-$0.01-$0.01N/M vs Q2 2012 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cytosorbents Corp · CIK 1175151 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,023,751— Margins · derivedGross margin31.5%
Operating margin-482.6%
Net margin-485.4%
ended Jun 30, 2013 · filed Aug 14, 2013 · 45 d after period end